Molecular Influenza Test Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Test Type (RT-PCR, LAMP, NASBA, TMA, Other); Flu Type (Type A Flu, Type B Flu, Type C Flu.); End-User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Contract Research Organizations (CROs)) and Geography

Report Code: TIPRE00022307 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Molecular diagnostic tests available for influenza include viral culture, serology, rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays.Influenza diagnostic tests are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative).

MARKET SCOPE

The "Global Molecular Influenza Test Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Molecular Influenza Test market with detailed market segmentation by Test type, Flu Type, end-User, and geography. The report provides key statistics on the market status of the leading Molecular Influenza Test market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on test type, the global Molecular Influenza Test market is segmented into RT-PCR, LAMP, NASBA, TMA,Other
  •   On the basis of Flu Type, the market is segmented into Type A Flu, Type B Flu, Type C Flu.
  •   Based on End- User, the global Molecular Influenza Test market is segmented into Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Contract Research Organizations (CROs)

MARKET DYNAMICS

Drivers-


  •   Increasing prevalence of influenza
  •   Growth in research funding for influenza diagnostics

Restraints-

  •   Variability in sensitivity and specificity among influenza diagnostic tests

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Molecular Influenza Test market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Molecular Influenza Test market in these regions.

IMPACT OF COVID-19 ON MOLECULAR INFLUENZA TEST MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. However, during a pandemic there are multiple concurrent clinical priorities, including the need to understand the pathophysiology of the disease, optimized patient care and prevention of future infections. The ongoing COVID-19 pandemic has surged the central position of diagnostic testing in outbreak control.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Molecular Influenza Test market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Molecular Influenza Test market are anticipated to lucrative growth opportunities in the future with the rising demand for Molecular Influenza Test in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Molecular Influenza Test market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   F. Hoffmann-La Roche
  •   Quidel Corporation
  •   Abbott Laboratories
  •   Becton, Dickinson, and Company
  •   Thermo Fisher Scientific
  •   DiaSorin
  •   BioMérieux
  •   Quidel Corporation
  •   Thermo Fisher Scientific
  •   Hologic

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1.INTRODUCTION
1.1.SCOPE OF THE STUDY
1.2.THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.MARKET SEGMENTATION
1.3.1Molecular Influenza Test Market - By Test Type
1.3.2Molecular Influenza Test Market - By Flu Type
1.3.3Molecular Influenza Test Market - By End-User
1.3.4Molecular Influenza Test Market - By Region
1.3.4.1By Country

2.KEY TAKEAWAYS

3.RESEARCH METHODOLOGY

4.MOLECULAR INFLUENZA TEST MARKET LANDSCAPE
4.1.OVERVIEW
4.2.PEST ANALYSIS
4.2.1North America - Pest Analysis
4.2.2Europe - Pest Analysis
4.2.3Asia-Pacific - Pest Analysis
4.2.4Middle East and Africa - Pest Analysis
4.2.5South and Central America - Pest Analysis
4.3.EXPERT OPINIONS

5.MOLECULAR INFLUENZA TEST MARKET - KEY MARKET DYNAMICS
5.1.KEY MARKET DRIVERS
5.2.KEY MARKET RESTRAINTS
5.3.KEY MARKET OPPORTUNITIES
5.4.FUTURE TRENDS
5.5.IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.MOLECULAR INFLUENZA TEST MARKET - GLOBAL MARKET ANALYSIS
6.1.MOLECULAR INFLUENZA TEST - GLOBAL MARKET OVERVIEW
6.2.MOLECULAR INFLUENZA TEST - GLOBAL MARKET AND FORECAST TO 2028
6.3.MARKET POSITIONING

7.MOLECULAR INFLUENZA TEST MARKET - REVENUE AND FORECASTS TO 2028 â" TEST TYPE
7.1.OVERVIEW
7.2.TEST TYPE MARKET FORECASTS AND ANALYSIS
7.3.RT-PCR
7.3.1.Overview
7.3.2.RT-PCR Market Forecast and Analysis
7.4.LAMP
7.4.1.Overview
7.4.2.LAMP Market Forecast and Analysis
7.5.NASBA
7.5.1.Overview
7.5.2.NASBA Market Forecast and Analysis
7.6.TMA
7.6.1.Overview
7.6.2.TMA Market Forecast and Analysis
7.7.OTHER
7.7.1.Overview
7.7.2.Other Market Forecast and Analysis
8.MOLECULAR INFLUENZA TEST MARKET - REVENUE AND FORECASTS TO 2028 â" FLU TYPE
8.1.OVERVIEW
8.2.FLU TYPE MARKET FORECASTS AND ANALYSIS
8.3.TYPE A FLU
8.3.1.Overview
8.3.2.Type A Flu Market Forecast and Analysis
8.4.TYPE B FLU
8.4.1.Overview
8.4.2.Type B Flu Market Forecast and Analysis
8.5.TYPE C FLU.
8.5.1.Overview
8.5.2.Type C Flu. Market Forecast and Analysis
9.MOLECULAR INFLUENZA TEST MARKET - REVENUE AND FORECASTS TO 2028 â" END-USER
9.1.OVERVIEW
9.2.END-USER MARKET FORECASTS AND ANALYSIS
9.3.HOSPITALS
9.3.1.Overview
9.3.2.Hospitals Market Forecast and Analysis
9.4.DIAGNOSTIC LABORATORIES
9.4.1.Overview
9.4.2.Diagnostic Laboratories Market Forecast and Analysis
9.5.RESEARCH AND ACADEMIC INSTITUTES
9.5.1.Overview
9.5.2.Research and Academic Institutes Market Forecast and Analysis
9.6.CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.6.1.Overview
9.6.2.Contract Research Organizations (CROs) Market Forecast and Analysis

10.MOLECULAR INFLUENZA TEST MARKET REVENUE AND FORECASTS TO 2028 â" GEOGRAPHICAL ANALYSIS
10.1.NORTH AMERICA
10.1.1North America Molecular Influenza Test Market Overview
10.1.2North America Molecular Influenza Test Market Forecasts and Analysis
10.1.3North America Molecular Influenza Test Market Forecasts and Analysis - By Test Type
10.1.4North America Molecular Influenza Test Market Forecasts and Analysis - By Flu Type
10.1.5North America Molecular Influenza Test Market Forecasts and Analysis - By End-User
10.1.6North America Molecular Influenza Test Market Forecasts and Analysis - By Countries
10.1.6.1United States Molecular Influenza Test Market
10.1.6.1.1United States Molecular Influenza Test Market by Test Type
10.1.6.1.2United States Molecular Influenza Test Market by Flu Type
10.1.6.1.3United States Molecular Influenza Test Market by End-User
10.1.6.2Canada Molecular Influenza Test Market
10.1.6.2.1Canada Molecular Influenza Test Market by Test Type
10.1.6.2.2Canada Molecular Influenza Test Market by Flu Type
10.1.6.2.3Canada Molecular Influenza Test Market by End-User
10.1.6.3Mexico Molecular Influenza Test Market
10.1.6.3.1Mexico Molecular Influenza Test Market by Test Type
10.1.6.3.2Mexico Molecular Influenza Test Market by Flu Type
10.1.6.3.3Mexico Molecular Influenza Test Market by End-User
10.2.EUROPE
10.2.1Europe Molecular Influenza Test Market Overview
10.2.2Europe Molecular Influenza Test Market Forecasts and Analysis
10.2.3Europe Molecular Influenza Test Market Forecasts and Analysis - By Test Type
10.2.4Europe Molecular Influenza Test Market Forecasts and Analysis - By Flu Type
10.2.5Europe Molecular Influenza Test Market Forecasts and Analysis - By End-User
10.2.6Europe Molecular Influenza Test Market Forecasts and Analysis - By Countries
10.2.6.1Germany Molecular Influenza Test Market
10.2.6.1.1Germany Molecular Influenza Test Market by Test Type
10.2.6.1.2Germany Molecular Influenza Test Market by Flu Type
10.2.6.1.3Germany Molecular Influenza Test Market by End-User
10.2.6.2France Molecular Influenza Test Market
10.2.6.2.1France Molecular Influenza Test Market by Test Type
10.2.6.2.2France Molecular Influenza Test Market by Flu Type
10.2.6.2.3France Molecular Influenza Test Market by End-User
10.2.6.3Italy Molecular Influenza Test Market
10.2.6.3.1Italy Molecular Influenza Test Market by Test Type
10.2.6.3.2Italy Molecular Influenza Test Market by Flu Type
10.2.6.3.3Italy Molecular Influenza Test Market by End-User
10.2.6.4Spain Molecular Influenza Test Market
10.2.6.4.1Spain Molecular Influenza Test Market by Test Type
10.2.6.4.2Spain Molecular Influenza Test Market by Flu Type
10.2.6.4.3Spain Molecular Influenza Test Market by End-User
10.2.6.5United Kingdom Molecular Influenza Test Market
10.2.6.5.1United Kingdom Molecular Influenza Test Market by Test Type
10.2.6.5.2United Kingdom Molecular Influenza Test Market by Flu Type
10.2.6.5.3United Kingdom Molecular Influenza Test Market by End-User
10.2.6.6Rest of Europe Molecular Influenza Test Market
10.2.6.6.1Rest of Europe Molecular Influenza Test Market by Test Type
10.2.6.6.2Rest of Europe Molecular Influenza Test Market by Flu Type
10.2.6.6.3Rest of Europe Molecular Influenza Test Market by End-User
10.3.ASIA-PACIFIC
10.3.1Asia-Pacific Molecular Influenza Test Market Overview
10.3.2Asia-Pacific Molecular Influenza Test Market Forecasts and Analysis
10.3.3Asia-Pacific Molecular Influenza Test Market Forecasts and Analysis - By Test Type
10.3.4Asia-Pacific Molecular Influenza Test Market Forecasts and Analysis - By Flu Type
10.3.5Asia-Pacific Molecular Influenza Test Market Forecasts and Analysis - By End-User
10.3.6Asia-Pacific Molecular Influenza Test Market Forecasts and Analysis - By Countries
10.3.6.1Australia Molecular Influenza Test Market
10.3.6.1.1Australia Molecular Influenza Test Market by Test Type
10.3.6.1.2Australia Molecular Influenza Test Market by Flu Type
10.3.6.1.3Australia Molecular Influenza Test Market by End-User
10.3.6.2China Molecular Influenza Test Market
10.3.6.2.1China Molecular Influenza Test Market by Test Type
10.3.6.2.2China Molecular Influenza Test Market by Flu Type
10.3.6.2.3China Molecular Influenza Test Market by End-User
10.3.6.3India Molecular Influenza Test Market
10.3.6.3.1India Molecular Influenza Test Market by Test Type
10.3.6.3.2India Molecular Influenza Test Market by Flu Type
10.3.6.3.3India Molecular Influenza Test Market by End-User
10.3.6.4Japan Molecular Influenza Test Market
10.3.6.4.1Japan Molecular Influenza Test Market by Test Type
10.3.6.4.2Japan Molecular Influenza Test Market by Flu Type
10.3.6.4.3Japan Molecular Influenza Test Market by End-User
10.3.6.5South Korea Molecular Influenza Test Market
10.3.6.5.1South Korea Molecular Influenza Test Market by Test Type
10.3.6.5.2South Korea Molecular Influenza Test Market by Flu Type
10.3.6.5.3South Korea Molecular Influenza Test Market by End-User
10.3.6.6Rest of Asia-Pacific Molecular Influenza Test Market
10.3.6.6.1Rest of Asia-Pacific Molecular Influenza Test Market by Test Type
10.3.6.6.2Rest of Asia-Pacific Molecular Influenza Test Market by Flu Type
10.3.6.6.3Rest of Asia-Pacific Molecular Influenza Test Market by End-User
10.4.MIDDLE EAST AND AFRICA
10.4.1Middle East and Africa Molecular Influenza Test Market Overview
10.4.2Middle East and Africa Molecular Influenza Test Market Forecasts and Analysis
10.4.3Middle East and Africa Molecular Influenza Test Market Forecasts and Analysis - By Test Type
10.4.4Middle East and Africa Molecular Influenza Test Market Forecasts and Analysis - By Flu Type
10.4.5Middle East and Africa Molecular Influenza Test Market Forecasts and Analysis - By End-User
10.4.6Middle East and Africa Molecular Influenza Test Market Forecasts and Analysis - By Countries
10.4.6.1South Africa Molecular Influenza Test Market
10.4.6.1.1South Africa Molecular Influenza Test Market by Test Type
10.4.6.1.2South Africa Molecular Influenza Test Market by Flu Type
10.4.6.1.3South Africa Molecular Influenza Test Market by End-User
10.4.6.2Saudi Arabia Molecular Influenza Test Market
10.4.6.2.1Saudi Arabia Molecular Influenza Test Market by Test Type
10.4.6.2.2Saudi Arabia Molecular Influenza Test Market by Flu Type
10.4.6.2.3Saudi Arabia Molecular Influenza Test Market by End-User
10.4.6.3U.A.E Molecular Influenza Test Market
10.4.6.3.1U.A.E Molecular Influenza Test Market by Test Type
10.4.6.3.2U.A.E Molecular Influenza Test Market by Flu Type
10.4.6.3.3U.A.E Molecular Influenza Test Market by End-User
10.4.6.4Rest of Middle East and Africa Molecular Influenza Test Market
10.4.6.4.1Rest of Middle East and Africa Molecular Influenza Test Market by Test Type
10.4.6.4.2Rest of Middle East and Africa Molecular Influenza Test Market by Flu Type
10.4.6.4.3Rest of Middle East and Africa Molecular Influenza Test Market by End-User
10.5.SOUTH AND CENTRAL AMERICA
10.5.1South and Central America Molecular Influenza Test Market Overview
10.5.2South and Central America Molecular Influenza Test Market Forecasts and Analysis
10.5.3South and Central America Molecular Influenza Test Market Forecasts and Analysis - By Test Type
10.5.4South and Central America Molecular Influenza Test Market Forecasts and Analysis - By Flu Type
10.5.5South and Central America Molecular Influenza Test Market Forecasts and Analysis - By End-User
10.5.6South and Central America Molecular Influenza Test Market Forecasts and Analysis - By Countries
10.5.6.1Brazil Molecular Influenza Test Market
10.5.6.1.1Brazil Molecular Influenza Test Market by Test Type
10.5.6.1.2Brazil Molecular Influenza Test Market by Flu Type
10.5.6.1.3Brazil Molecular Influenza Test Market by End-User
10.5.6.2Argentina Molecular Influenza Test Market
10.5.6.2.1Argentina Molecular Influenza Test Market by Test Type
10.5.6.2.2Argentina Molecular Influenza Test Market by Flu Type
10.5.6.2.3Argentina Molecular Influenza Test Market by End-User
10.5.6.3Rest of South and Central America Molecular Influenza Test Market
10.5.6.3.1Rest of South and Central America Molecular Influenza Test Market by Test Type
10.5.6.3.2Rest of South and Central America Molecular Influenza Test Market by Flu Type
10.5.6.3.3Rest of South and Central America Molecular Influenza Test Market by End-User

11.INDUSTRY LANDSCAPE
11.1.MERGERS AND ACQUISITIONS
11.2.AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3.NEW PRODUCT LAUNCHES
11.4.EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12.MOLECULAR INFLUENZA TEST MARKET, KEY COMPANY PROFILES
12.1.F. HOFFMANN-LA ROCHE
12.1.1.Key Facts
12.1.2.Business Description
12.1.3.Products and Services
12.1.4.Financial Overview
12.1.5.SWOT Analysis
12.1.6.Key Developments
12.2.QUIDEL CORPORATION
12.2.1.Key Facts
12.2.2.Business Description
12.2.3.Products and Services
12.2.4.Financial Overview
12.2.5.SWOT Analysis
12.2.6.Key Developments
12.3.ABBOTT LABORATORIES
12.3.1.Key Facts
12.3.2.Business Description
12.3.3.Products and Services
12.3.4.Financial Overview
12.3.5.SWOT Analysis
12.3.6.Key Developments
12.4.BECTON, DICKINSON, AND COMPANY
12.4.1.Key Facts
12.4.2.Business Description
12.4.3.Products and Services
12.4.4.Financial Overview
12.4.5.SWOT Analysis
12.4.6.Key Developments
12.5.THERMO FISHER SCIENTIFIC
12.5.1.Key Facts
12.5.2.Business Description
12.5.3.Products and Services
12.5.4.Financial Overview
12.5.5.SWOT Analysis
12.5.6.Key Developments
12.6.DIASORIN
12.6.1.Key Facts
12.6.2.Business Description
12.6.3.Products and Services
12.6.4.Financial Overview
12.6.5.SWOT Analysis
12.6.6.Key Developments
12.7.BIOMéRIEUX
12.7.1.Key Facts
12.7.2.Business Description
12.7.3.Products and Services
12.7.4.Financial Overview
12.7.5.SWOT Analysis
12.7.6.Key Developments
12.8.QUIDEL CORPORATION
12.8.1.Key Facts
12.8.2.Business Description
12.8.3.Products and Services
12.8.4.Financial Overview
12.8.5.SWOT Analysis
12.8.6.Key Developments
12.9.THERMO FISHER SCIENTIFIC
12.9.1.Key Facts
12.9.2.Business Description
12.9.3.Products and Services
12.9.4.Financial Overview
12.9.5.SWOT Analysis
12.9.6.Key Developments
12.10.HOLOGIC
12.10.1.Key Facts
12.10.2.Business Description
12.10.3.Products and Services
12.10.4.Financial Overview
12.10.5.SWOT Analysis
12.10.6.Key Developments

13.APPENDIX
13.1.ABOUT THE INSIGHT PARTNERS
13.2.GLOSSARY OF TERMS
The List of Companies

1. Hoffmann-La Roche
2. Quidel Corporation
3. Abbott Laboratories
4. Becton, Dickinson, and Company
5. Thermo Fisher Scientific
6. DiaSorin, bioMérieux,
7. Quidel Corporation
8. Thermo Fisher Scientific
9. Hologic
10. SA Scientific
11. Sekisui Diagnostics
12. bioMérieux SA
13. Danaher Corporation
14. Siemens Healthineers
15. Response Biomedical
TIPRE00022307
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking